Navigation Links
Sysmex America Announces Amerinet Urinalysis Contract
Date:7/8/2010

MUNDELEIN, Ill., July 8 /PRNewswire/ -- Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced a three-year, dual source urinalysis contract agreement with Amerinet.  Amerinet members have immediate purchasing/leasing access to Sysmex automated urine particle analyzers, reagents, controls, and service.  Training and technical support for Amerinet members will be provided through Sysmex America's U.S. headquarters in Mundelein, Illinois.  The contract which was awarded on technical merit and pricing also includes Sysmex e-Tools™, a comprehensive set of systems and resources that support a clinical laboratory's long-term success before, during and after instrument or system implementation.  Amerinet is a leading national healthcare group purchasing organization that strategically partners with more than 41,000 healthcare providers to reduce costs and improve quality.

"We at Sysmex America are especially pleased to serve as Amerinet's partner in supporting their member-laboratories' needs to automate microscopic urinalysis – typically a very time-consuming endeavor when performed manually.  We trust that Amerinet members will embrace the reliability and uptime of our instruments as they work to provide high quality, cost-effective patient care in a competitive healthcare environment," said John Kershaw, President & CEO, Sysmex America, Inc.  

As proven with other laboratory disciplines, automation provides for standardized, high-quality results that can be reported in a timely fashion for urine samples as well.  Sysmex developed the first fully automated urine cell analyzer in the world – the Sysmex UF-100™, making its debut in Japan in 1995 and in the United States in 1996.  Since that time, Sysmex introduced its UF-1000i™ automated urine particle analyzer.  The Sysmex UF-1000i combines the advanced technology of fluorescent flow cytometry with fully automated urine sample analysis, providing walk away capability and standardization.  

About Amerinet

As a leading national healthcare group purchasing organization, Amerinet strategically partners with acute and alternate care providers to reduce costs and improve quality through its performance solutions. Built on a foundation of data, savings and trust, and supported by a team of clinical and supply chain experts, Amerinet enriches healthcare delivery for its members and the communities they serve. To learn more about the Amerinet difference, visit www.amerinet-gpo.com.

About Sysmex America, Inc.

Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems.  Serving customers for over 40 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide.  For more information about Sysmex, please visit www.sysmex.com/usa.


'/>"/>
SOURCE Sysmex America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sysmex America Announces Executive Leadership Changes
2. Sysmex America Honored Second Consecutive Year as a Company That Cares
3. Sysmex America Adds Industry Veteran to Company Leadership
4. OhioHealth Installs Newest Version of Sysmexs Hematology Middleware, Sysmex WAM(TM) 4.0
5. Exagen Diagnostics Receives Lab Accreditation From College of American Pathologists
6. Profil Institute Teams Up With American Diabetes Association to Step Out Against Diabetes
7. Hot Times in the City: As Summer Temperatures Soar, Pulse of Passion Survey Reveals What Makes Americans Sizzle in Relationships
8. Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
9. Breast Cancer Patient First in Latin America to Receive Treatment Using Elekta VMAT Planned with Monaco Software
10. Dr. Harry J. Guttman, Esq. Invited Speaker at 2010 Central Regional Meeting of the American Chemical Society
11. InteKrin Therapeutics Presented Phase 2b Clinical Data at the 2010 American Diabetes Association Annual Meeting, Demonstrating Improved Glycemic Control in Patients with Type 2 Diabetes Without Causing the Edema Seen with Pioglitazone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Research and Markets has announced the addition of the ... ... The global chromatography market to grow at a CAGR of 5.42% during ... prepared based on an in-depth market analysis with inputs from industry experts. ... coming years. The report also includes a discussion of the key vendors ...
(Date:12/8/2016)... 2016 According to a ... Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners), Type ... Agents), Formulation (Oral, Topical, Parenteral) - Global Forecast ... witnessed healthy growth during the last decade, and ... 4.3% between 2016 and 2021 to reach USD ...
(Date:12/8/2016)... SAN FRANCISCO, Calif. , Dec. 8, 2016 ... nuclease technology to develop novel antiviral therapeutics, today ... M.D., as chief executive officer and a member ... is an incredibly experienced executive with a deep ... said Stephen Quake, D.Phil., founder of Agenovir, co-president ...
Breaking Medicine Technology:
(Date:12/8/2016)... Fla (PRWEB) , ... December 08, 2016 , ... ... smarter modes of access for customers and employees that are both engaging and ... 7 with Service Smart Technology, the software company revealed today its plans to ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... up in 2006 as a non-profit organization to unite pharmaceutical and healthcare companies ...
(Date:12/8/2016)... ... 2016 , ... STAT courier is pleased to announce that due to customer ... are expanding their presence in Dallas. One of the most exciting parts for STAT ... to the Dallas and Forth Worth market. STAT takes pride in treating their employees ...
(Date:12/8/2016)... City, Ga (PRWEB) , ... December 08, 2016 ... ... moving as soon after surgery as possible. With this in mind, SIGVARIS has ... thrombosis (DVT or blood clot) during bed rest and provide the benefits of ...
(Date:12/8/2016)... , ... December 08, 2016 , ... Vida ... an $18M Series B led by Canvas Ventures . Other investors include Nokia ... scale its mobile platform to serve more consumers who are managing chronic conditions ...
Breaking Medicine News(10 mins):